Flomics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

Flomics General Information

Description

Operator of a molecular diagnostics company intended to improve clinical practice development of a multi-disease detection test from a standard blood sample. The company offers a liquid biopsy solution that uses a simple blood draw to analyze circulating ribonucleic acid (RNA) molecules, which can be done through their machine learning model to interpret and identify disease signatures, enabling healthcare providers with timely intervention before symptoms appear.

Contact Information

Website
www.flomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cosymbio Labs
  • Carrer de Roc Boronat, 31
  • 08005 Barcelona
  • Spain
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • Cosymbio Labs
  • Carrer de Roc Boronat, 31
  • 08005 Barcelona
  • Spain

Flomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Generating Revenue
4. Equity Crowdfunding 12-Jul-2024 Completed Generating Revenue
3. Seed Round 06-Mar-2024 Completed Generating Revenue
2. Seed Round 28-Mar-2022 $1.1M $1.1M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Flomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Flomics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Flomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025176812-A1 Colon cancer biomarkers Pending 21-Feb-2024

Flomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Flomics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Decelera Ventures Accelerator/Incubator Minority
Fundo Bem Commons FCR Venture Capital Minority
Histemi Inversiones Venture Capital Minority
Instituto Oncologico Dr Rosell Corporation Minority
Arcano Asesores Financieros Investment Bank Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Flomics FAQs

  • When was Flomics founded?

    Flomics was founded in 2018.

  • Where is Flomics headquartered?

    Flomics is headquartered in Barcelona, Spain.

  • What is the size of Flomics?

    Flomics has 20 total employees.

  • What industry is Flomics in?

    Flomics’s primary industry is Diagnostic Equipment.

  • Is Flomics a private or public company?

    Flomics is a Private company.

  • What is Flomics’s current revenue?

    The current revenue for Flomics is .

  • How much funding has Flomics raised over time?

    Flomics has raised $3.15M.

  • Who are Flomics’s investors?

    Decelera Ventures, Fundo Bem Commons FCR, Histemi Inversiones, Instituto Oncologico Dr Rosell, and Arcano Asesores Financieros are 5 of 8 investors who have invested in Flomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process